US Patent Issued to Cartesian Therapeutics on Feb. 17 for "Formulations and doses of pegylated uricase" (Massachusetts, Georgia Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,041, issued on Feb. 17, was assigned to Cartesian Therapeutics Inc. (Frederick, Md.).

"Formulations and doses of pegylated uricase" was invented by Lloyd Johnston (Belmont, Mass.), Takashi Kei Kishimoto (Lexington, Mass.), Earl Sands (Alpharetta, Ga.) and Werner Cautreels (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions and kits related to identification and/or treatment of subjects, including subjects with hyperuricemia, gout or a condition associated with gout, and for preventing gout flare."

The patent was filed on June 4, 2020, under Application No. 16/893,153.

*For further information, includ...